Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.9B
AUM Growth
-$531M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,809
New
Increased
Reduced
Closed

Top Buys

1 +$800M
2 +$304M
3 +$261M
4
LIN icon
Linde
LIN
+$237M
5
JPM icon
JPMorgan Chase
JPM
+$208M

Top Sells

1 +$656M
2 +$632M
3 +$474M
4
PG icon
Procter & Gamble
PG
+$428M
5
MU icon
Micron Technology
MU
+$332M

Sector Composition

1 Technology 22.08%
2 Healthcare 15.35%
3 Industrials 11.11%
4 Consumer Discretionary 10.88%
5 Financials 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZO icon
3651
MarineMax
HZO
$769M
-15,200
IART icon
3652
Integra LifeSciences
IART
$1.17B
-14,760
IAUM icon
3653
iShares Gold Trust Micro
IAUM
$7.07B
-106,600
IBIO icon
3654
iBio
IBIO
$91.4M
-353,339
IBRX icon
3655
ImmunityBio
IBRX
$7.56B
-1,231,770
ICFI icon
3656
ICF International
ICFI
$1.25B
-47,100
IDA icon
3657
Idacorp
IDA
$7.87B
-41,100
IDV icon
3658
iShares International Select Dividend ETF
IDV
$8.61B
-8,800
IEV icon
3659
iShares Europe ETF
IEV
$1.75B
-3,600
IGM icon
3660
iShares Expanded Tech Sector ETF
IGM
$10.5B
-14,000
IHI icon
3661
iShares US Medical Devices ETF
IHI
$3.2B
-29,100
IJR icon
3662
iShares Core S&P Small-Cap ETF
IJR
$103B
-17,500
ILF icon
3663
iShares Latin America 40 ETF
ILF
$4.71B
-134,700
IMMX icon
3664
Immix Biopharma
IMMX
$625M
-258,600
IMTM icon
3665
iShares MSCI Intl Momentum Factor ETF
IMTM
$3.98B
-14,800
INDB icon
3666
Independent Bank
INDB
$3.8B
-18,002
INKT icon
3667
MiNK Therapeutics
INKT
$54.2M
-10,400
INOD icon
3668
Innodata
INOD
$3.12B
-25,854
INTR icon
3669
Inter&Co
INTR
$2.72B
-436,520
IOBT
3670
DELISTED
IO Biotech
IOBT
-207,601
IOVA icon
3671
Iovance Biotherapeutics
IOVA
$1.84B
-651,000
IQLT icon
3672
iShares MSCI Intl Quality Factor ETF
IQLT
$13.4B
-25,200
ISTB icon
3673
iShares Core 1-5 Year USD Bond ETF
ISTB
$4.69B
-41,800
ITB icon
3674
iShares US Home Construction ETF
ITB
$2.4B
-10,600
ITOT icon
3675
iShares Core S&P Total US Stock Market ETF
ITOT
$91.8B
-86,800